Cover Image

Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018-2019.

<h4>Background</h4>Scabies is a common skin infestation caused by the Sarcoptes scabei mite. Ivermectin, one of three drugs used in mass drug administration (MDA) for lymphatic filariasis, is also effective for treating scabies. Ivermectin-based MDA was first conducted in Samoa in August...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gabriela A Willis (Author), Therese Kearns (Author), Helen J Mayfield (Author), Sarah Sheridan (Author), Robert Thomsen (Author), Take Naseri (Author), Michael C David (Author), Daniel Engelman (Author), Andrew C Steer (Author), Patricia M Graves (Author), Colleen L Lau (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2023-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018.
by: Gabriela A Willis, et al.
Published: (2020)

Lymphatic filariasis epidemiology in Samoa in 2018: Geographic clustering and higher antigen prevalence in older age groups.
by: Colleen L Lau, et al.
Published: (2020)

Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration.
by: Helen J Mayfield, et al.
Published: (2024)

Field laboratory comparison of STANDARD Q Filariasis Antigen Test (QFAT) with Bioline Filariasis Test Strip (FTS) for the detection of Lymphatic Filariasis in Samoa, 2023.
by: Jessica L Scott, et al.
Published: (2024)

Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame.
by: Colleen L Lau, et al.
Published: (2016)

Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration.
by: Colleen L Lau, et al.
Published: (2017)

Seroprevalence and spatial epidemiology of Lymphatic Filariasis in American Samoa after successful mass drug administration.
by: Colleen L Lau, et al.
Published: (2014)

Lymphatic filariasis in 2016 in American Samoa: Identifying clustering and hotspots using non-spatial and three spatial analytical methods.
by: Kinley Wangdi, et al.
Published: (2022)

Lymphatic filariasis endgame strategies: Using GEOFIL to model mass drug administration and targeted surveillance and treatment strategies in American Samoa.
by: Callum Shaw, et al.
Published: (2023)

Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.
by: Meru Sheel, et al.
Published: (2018)

Potential strategies for strengthening surveillance of lymphatic filariasis in American Samoa after mass drug administration: Reducing 'number needed to test' by targeting older age groups, hotspots, and household members of infected persons.
by: Colleen L Lau, et al.
Published: (2020)

Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa.
by: Kimberly Y Won, et al.
Published: (2018)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016)

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis.
by: Abdullah Alshehri, et al.
Published: (2023)

Molecular xenomonitoring using mosquitoes to map lymphatic filariasis after mass drug administration in American Samoa.
by: Mark A Schmaedick, et al.
Published: (2014)

Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children.
by: Amanda Gwee, et al.
Published: (2020)

Population pharmacokinetics of ivermectin after mass drug administration in lymphatic filariasis endemic communities of Tanzania
by: Adam M. Fimbo, et al.
Published: (2023)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
by: Achille S Nikièma, et al.
Published: (2021)

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.
by: Paul E Simonsen, et al.
Published: (2010)

Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
by: Inge Kroidl, et al.
Published: (2016)

Ivermectin worthy of further investigation
by: Andrew C Steer, et al.
Published: (2009)

Lymphatic Filariasis in Sri Lanka
by: C. Harriet Gautamadasa
Published: (2001)

Correction: Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
by: Inge Kroidl, et al.
Published: (2016)

Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands.
by: Suny Coscione, et al.
Published: (2018)

Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community.
by: Thérèse M Kearns, et al.
Published: (2015)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
by: Peter U Fischer, et al.
Published: (2017)

Elimination of lymphatic filariasis in the Gambia.
by: Maria P Rebollo, et al.
Published: (2015)

Ivermectin efficacy still imprecise for scabies treatment
by: Antoine Mahé, et al.
Published: (2009)

Scabies and impetigo in Samoa: A school-based clinical and molecular epidemiological study
by: George Taiaroa, et al.
Published: (2021)

Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study.
by: Catherine M Bjerum, et al.
Published: (2023)

Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study
by: Adam M. Fimbo, et al.
Published: (2024)

Associations between socioeconomic resources and adiposity traits in adults: Evidence from Samoa
by: Courtney C. Choy, et al.
Published: (2020)

Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin
by: Lawrence Gregor, et al.
Published: (2005)

Maximizing the Use of Ivermectin Transethosomal Cream in the Treatment of Scabies
by: Mohammad H. Alyami, et al.
Published: (2024)

Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment.
by: Sammy M Njenga, et al.
Published: (2024)

Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study
by: Adam M. Fimbo, et al.
Published: (2022)

One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trial.
by: Susanna J Lake, et al.
Published: (2023)

Leptospirosis in American Samoa--estimating and mapping risk using environmental data.
by: Colleen L Lau, et al.
Published: (2012)

Topical Ivermectin for Permethrin-Resistant Scabies: A Useful Application
by: Laura Gnesotto, et al.
Published: (2024)

How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis.
by: Randee J Kastner, et al.
Published: (2017)